The pharmacokinetics of ibuprofen suspension, chewable tablets, and tablets in children with cystic fibrosis
- 1 January 1999
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 134 (1) , 58-63
- https://doi.org/10.1016/s0022-3476(99)70387-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Lower Airway Inflammation in Infants and Young Children with Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Nasal and Bronchoalveolar Lavage Fluid Cytokines in Early Cystic FibrosisThe Journal of Infectious Diseases, 1997
- Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosisBMJ, 1995
- A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosisThe Journal of Pediatrics, 1995
- Effect of High-Dose Ibuprofen in Patients with Cystic FibrosisNew England Journal of Medicine, 1995
- Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.American Journal of Respiratory and Critical Care Medicine, 1994
- Direct determination of ibuprofen and ibuprofen acyl glucuronide in plasma by high-performance liquid chromatography using solid-phase extractionJournal of Chromatography B: Biomedical Sciences and Applications, 1993
- Effect of age on ibuprofen pharmacokinetics and antipyretic responseThe Journal of Pediatrics, 1992
- Ibuprofen in children with cystic fibrosis: Pharmacokinetics and adverse effectsThe Journal of Pediatrics, 1991
- ALTERNATE-DAY PREDNISONE REDUCES MORBIDITY AND IMPROVES PULMONARY FUNCTION IN CYSTIC FIBROSISThe Lancet, 1985